샘플 요청 목록

 카트 문의
시장보고서
상품코드
1709463

세계의 헬리코박터 파일로리 비침습 검사 시장 : 검사 유형별, 기술별, 유통 채널별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

Non-invasive Helicobacter Pylori Testing Market, By Test Type, By Technology, By Distribution, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 298 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

헬리코박터 파일로리 비침습 검사 시장 규모는 2024년 2억 9,733만 달러로 평가되었고, 2025-2032년 연평균 7.50% 성장할 것으로 예상됩니다.

헬리코박터 파일로리 비침습 검사 시장 역학

편의성을 추구한 가정용 헬리코박터 파일로리균 검사 키트에 대한 수요 증가

가정용 헬리코박터 파일로리 검사 키트에 대한 수요 증가는 헬리코박터 파일로리 비침습 검사 시장의 주요 촉진요인입니다. 소비자들은 병원 방문의 필요성을 없애는 편리한 가정 진단 솔루션을 선호합니다. 이러한 키트는 프라이버시를 보호하고, 사용하기 쉽고, 빠른 결과를 얻을 수 있어 조기 발견을 위해 매력적입니다. 원격 의료 및 디지털 의료 플랫폼의 등장으로 검사 결과를 기반으로 한 원격 진료가 가능해져 그 채택을 더욱 촉진하고 있습니다. 또한, 위 질환 및 예방 의료에 대한 인식이 높아지면서 시장 성장을 가속하고 있습니다. 신속 항원 검사 및 호흡 검사 기술의 발전은 재택 검사의 정확성과 신뢰성을 향상시킵니다. 자가 검사 솔루션에 대한 규제 당국의 승인은 특히 의료 인프라가 제한된 지역에서 접근성을 확대하고 있으며, 전자상거래의 확산은 이러한 키트를 널리 이용할 수 있게 함으로써 판매를 촉진하고 있습니다. 의료가 개인 맞춤형 의료와 예방 의료로 전환됨에 따라 가정용 헬리코박터 파일로리 검사에 대한 수요가 증가할 것으로 예상됩니다.

헬리코박터 파일로리 비침습 검사 시장 : 주요 고려사항

당사의 리서치 애널리스트들이 공유한 분석에 따르면, 세계 시장은 예측 기간(2025-2032년) 동안 매년 약 7.50%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예측됩니다.

검사 유형별로는 우레아 호흡 검사(UBT)가 2024년 가장 큰 시장 점유율을 차지했습니다.

기술별로는 2024년 분자진단법이 주요 기술이었습니다.

유통 채널별로는 2024년 병원 약국이 주요 유통 채널이었습니다.

최종 사용자별로는 2024년 병원 및 클리닉이 주요 최종 사용자로 나타났습니다.

지역별로는 아시아태평양이 2024년 매출을 주도했습니다.

헬리코박터 파일로리 비침습 검사 시장 : 세분화 분석

헬리코박터 파일로리 비침습 검사 세계 시장은 검사 유형, 기술, 유통, 최종 사용자, 지역에 따라 세분화됩니다.

시장은 검사 유형에 따라 우레아 호흡 검사(UBT), 대변 항원 검사(SAT), 혈액 항체 검사 등 세 가지 범주로 나뉩니다. 요소호기검사(UBT)는 높은 정확도, 사용 편의성, 활동성 감염 검출에 대한 신뢰성으로 비침습적 헬리코박터 파일로리균 검사 시장을 독점하고 있습니다. 과거와 현재 감염을 구분할 수 없는 혈액 항체 검사와 달리 UBT는 헬리코박터 파일로리균의 존재를 나타내는 중요한 마커인 우레아제 효소 활성을 직접 측정합니다. 비침습적이고 결과가 빠르기 때문에 병원, 진단 실험실, 재택 환경에서 널리 선호되고 있습니다.

UBT는 실시간 감염 상태를 제공하기 때문에 치료 모니터링 및 제균 확인을 위한 골드 스탠다드로 의료 전문가들의 지지를 받고 있습니다. 이 검사는 전 세계 보건 기관에서도 지지하고 있으며, 더욱 널리 보급되고 있습니다. 기술의 발전으로 휴대가 간편하고 사용하기 쉬운 호흡 검사 장비가 개발되어 접근성이 향상되었습니다. 또한, 위 질환의 유병률 증가와 정부 지원 검진 프로그램이 시장 성장을 뒷받침하고 있습니다. 효율적이고 환자 친화적인 진단에 대한 수요가 증가함에 따라 UBT는 여전히 헬리코박터 파일로리 비침습 검사로 가장 널리 사용되고 있습니다.

시장은 기술별로 분자진단법, 면역측정법, 크로마토그래피 기술 등 세 가지 범주로 분류됩니다. 분자진단법은 높은 민감도, 특이성, 낮은 균량 검출 능력으로 비침습적 헬리코박터 파일로리균 검사 시장을 독점하고 있습니다. 기존 방법과 달리 분자진단, 특히 중합효소연쇄반응(PCR) 기반 검사는 헬리코박터 파일로리 DNA를 직접 확인하므로 무증상 환자도 정확한 결과를 얻을 수 있습니다. 따라서 임상 실험실이나 조사 현장에서 선호되고 있습니다.

실시간 PCR(qPCR)과 차세대 염기서열 분석(NGS)의 채택이 진행되면서 진단 정확도가 더욱 향상되고 있습니다. 분자 검사는 빠른 결과를 제공하므로 반복 검사의 필요성을 줄이고 적시에 치료 결정을 내릴 수 있습니다. 또한, 이러한 기술은 항생제 내성을 감지하여 효과적인 치료 전략을 수립하는 데 도움을 줄 수 있습니다. 정부와 의료 기관은 위 질환 관리를 개선하기 위해 첨단 진단 기술을 추진하고 있으며, 이는 수요를 주도하고 있습니다. 진단 자동화 및 현장 분자 검사가 계속 발전하고 있는 가운데, 분자진단은 여전히 시장을 선도하는 기술입니다.

헬리코박터 파일로리 비침습 검사 시장 : 지역별 분석

아시아태평양의 비침습적 헬리코박터 파일로리균 검사 시장은 높은 헬리코박터 파일로리균 감염 유병률과 위장 질환에 대한 인식이 높아짐에 따라 성장하고 있습니다. 중국, 인도, 일본 등의 국가에서는 헬리코박터 파일로리균 관련 질환의 부담이 커서 조기 및 정확한 진단에 대한 수요가 증가하고 있습니다. 우레아호기검사(UBT)와 대변항원검사(SAT)의 신뢰성과 비침습성으로 인해 채택이 증가하고 있습니다. 위암 검진 프로그램을 장려하는 정부 이니셔티브는 시장 성장을 더욱 촉진하고 있습니다. 의료 인프라의 확장, 가처분 소득 증가, 의료 관광 증가로 인해 이 지역에서 고급 진단에 대한 접근성이 향상되고 있습니다. 또한, 전자상거래 플랫폼을 통해 재택 검사 키트를 쉽게 구할 수 있게 된 것도 시장 침투를 촉진하고 있습니다. 혁신적인 진단 솔루션에 대한 기술 발전과 규제 환경의 승인은 계속해서 시장 상황을 형성하고 있습니다.

중국 비침습적 헬리코박터 파일로리균 검사 시장은 인구의 약 50%가 헬리코박터 파일로리균에 감염되어 있는 높은 유병률로 인해 강력한 성장세를 보이고 있습니다. 위 질환, 궤양, 위암 위험에 대한 인식이 높아지면서 조기 비침습적 진단 방법에 대한 수요가 증가하고 있습니다. 중국 정부는 위암 검진 프로그램을 추진하고 있어 시장 확대에 더욱 박차를 가하고 있습니다.

우레아 호흡 검사(UBT)는 높은 정확도와 편리성으로 인해 중국에서 가장 널리 사용되는 방법입니다. 대변 항원 검사(SAT)의 채택도 병원과 진단 실험실를 중심으로 증가하고 있습니다. 한편, 전자상거래 플랫폼과 원격 의료 서비스의 부상으로 가정 내 헬리코박터 파일로리균 검사 키트의 이용 가능성이 높아지고 있습니다. 소비자들은 편의성, 저렴한 가격, 병원 방문 횟수 감소 등의 이유로 재택 진단을 선호하고 있습니다.

헬리코박터 파일로리 비침습 검사 시장 : 경쟁 구도

헬리코박터 파일로리 비침습 검사 시장은 경쟁이 치열하며, 업체들은 시장 점유율을 확대하기 위해 기술 발전, 제품 혁신, 전략적 제휴에 주력하고 있으며, Thermo Fisher Scientific, Abbott, DiaSorin 등 주요 업체들은 분자진단, 면역 측정 기반 키트, 요산 호흡 테스트 우레아 호흡 검사에서 우위를 점하고 있습니다. R&D 투자 증가로 검사 정확도가 향상되고, 진단 실험실의 자동화로 효율성이 향상되고 있습니다.

재택 검사 키트와 디지털 의료 솔루션의 등장으로 경쟁이 더욱 치열해지고 있습니다. 각 업체들은 특히 신흥 시장을 중심으로 세계 판매망을 확장하고 있습니다. 규제 당국의 승인과 정부의 지원으로 진행되는 검진 프로그램은 시장 역학에 지속적으로 영향을 미치고 있습니다.

목차

제1장 헬리코박터 파일로리 비침습 검사 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 헬리코박터 파일로리 비침습 검사 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 향후 동향

제4장 헬리코박터 파일로리 비침습 검사 시장 : 산업 분석

  • PEST 분석
  • Porter의 Five Forces 분석
  • 시장 성장 전망 : 맵핑
  • 규제 체제 분석

제5장 헬리코박터 파일로리 비침습 검사 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아-우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 헬리코박터 파일로리 비침습 검사 시장 구도

  • 헬리코박터 파일로리 비침습 검사 시장 점유율 분석(2024년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 헬리코박터 파일로리 비침습 검사 시장 : 검사 유형별

  • 개요
    • 부문별 점유율 분석 : 검사 유형별
    • 요소 호기 시험(UBT)
    • 변항원검사(SAT)
    • 혈액 항체 검사

제8장 헬리코박터 파일로리 비침습 검사 시장 : 기술별

  • 개요
    • 부문별 점유율 분석 : 기술별
    • 분자진단법
    • 면역진단법
    • 크로마토그래피 기술

제9장 헬리코박터 파일로리 비침습 검사 시장 : 유통 채널별

  • 개요
    • 부문별 점유율 분석 : 유통 채널별
    • 기계 번역 통합
    • 병원 약국
    • 소매 약국
    • 온라인 약국

제10장 헬리코박터 파일로리 비침습 검사 시장 : 최종사용자별

  • 개요
    • 부문별 점유율 분석 : 최종사용자별
    • 최종사용자별 부문 점유율 분석
    • 병원 및 진료소
    • 진단실험실
    • 재택치료

제11장 헬리코박터 파일로리 비침습 검사 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 : 헬리코박터 파일로리 비침습 검사 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 개요
    • Thermo Fisher Scientific Inc.
    • DiaSorin SpA
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • QuidelOrtho Corporation
    • Meridian Bioscience, Inc.
    • Coris BioConcept
    • Sekisui Diagnostics
    • Alfa Scientific Designs, Inc.
    • Halyard Health, Inc.
    • Kibion AB
    • Shenzhen Zhonghe Headway Bio-Sci &Tech Co., Ltd.
    • CerTest Biotec SL
    • BIOHIT HealthCare Ltd.
    • Medline Industries, LP
    • Cardinal Health, Inc.
    • Luminex Corporation

제13장 AnalystView의 전방위적 분석

LSH 25.05.07

REPORT HIGHLIGHT

Non-invasive Helicobacter Pylori Testing Market size was valued at US$ 297.33 Million in 2024, expanding at a CAGR of 7.50% from 2025 to 2032.

The non-invasive Helicobacter pylori (H. pylori) testing market focuses on diagnostic methods that detect infections without requiring endoscopic procedures. These tests include urea breath tests (UBT), stool antigen tests (SAT), and blood antibody tests. UBT is highly accurate, detecting urease enzyme activity, while SAT identifies bacterial antigens in stool samples. Blood tests check for antibodies but are less reliable for active infections. The market is driven by the high prevalence of H. pylori, linked to ulcers and gastric cancer, and the increasing preference for non-invasive diagnostics. Growing awareness, improved healthcare access, and advancements in point-of-care testing further boost demand. North America, Europe, and Asia-Pacific lead the market due to well-established healthcare systems and rising gastrointestinal disease cases. Regulatory approvals and innovations in diagnostic technology continue to shape market expansion.

Non-invasive Helicobacter Pylori Testing Market- Market Dynamics

Rising demand for home-based H. pylori testing kits for convenience.

The growing demand for home-based H. pylori testing kits is a key driver in the non-invasive H. pylori testing market. Consumers prefer convenient, at-home diagnostic solutions that eliminate the need for clinical visits. These kits offer privacy, ease of use, and quick results, making them attractive for early detection. The rise of telemedicine and digital healthcare platforms further supports their adoption, allowing remote consultations based on test results. Additionally, increasing awareness about gastric diseases and preventive healthcare fuels market growth. Advancements in rapid antigen and breath test technologies enhance the accuracy and reliability of at-home testing. Regulatory approvals for self-testing solutions are expanding accessibility, especially in regions with limited healthcare infrastructure. Growing e-commerce penetration also boosts sales, making these kits widely available. As healthcare shifts toward personalized and preventive medicine, home-based H. pylori tests are expected to see strong demand.

Non-invasive Helicobacter Pylori Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.50% over the forecast period (2025-2032)

Based on Test Type segmentation, Urea Breath Test (UBT) was predicted to show maximum market share in the year 2024

Based on Technology segmentation, Molecular Diagnostics was the leading Technology in 2024

Based on distribution segmentation, Hospital-Based Pharmacies was the leading distribution in 2024

Based on End-user segmentation, Hospitals & Clinics was the leading End-user in 2024

On the basis of region, Asia-Pacific was the leading revenue generator in 2024

Non-invasive Helicobacter Pylori Testing Market- Segmentation Analysis:

The Global Non-invasive Helicobacter Pylori Testing Market is segmented on the basis of Test Type, Technology, Distribution, end-user, and Region.

The market is divided into three categories based on Test Type: Urea Breath Test (UBT), Stool Antigen Test (SAT), Blood Antibody Test. The Urea Breath Test (UBT) dominates the non-invasive H. pylori testing market due to its high accuracy, ease of use, and reliability in detecting active infections. Unlike blood antibody tests, which cannot distinguish between past and present infections, UBT directly measures urease enzyme activity, a key marker of H. pylori presence. It is widely preferred in hospitals, diagnostic labs, and home-based settings due to its non-invasive nature and quick results.

Healthcare professionals favor UBT because it provides real-time infection status, making it the gold standard for treatment monitoring and eradication confirmation. The test is also endorsed by global health organizations, further increasing adoption. Technological advancements have led to portable and easy-to-use breath test devices, enhancing accessibility. Additionally, the rising prevalence of gastric diseases and government-backed screening programs support market growth. With increasing demand for efficient and patient-friendly diagnostics, UBT remains the most widely used non-invasive H. pylori test.

The market is divided into three categories based on Technology: Molecular Diagnostics, Immunoassay-Based Testing, Chromatographic Techniques. Molecular Diagnostics dominates the non-invasive H. pylori testing market due to its high sensitivity, specificity, and ability to detect low bacterial loads. Unlike traditional methods, molecular diagnostics, particularly Polymerase Chain Reaction (PCR)-based tests, identify H. pylori DNA directly, ensuring accurate results even in asymptomatic patients. This makes it a preferred choice in clinical laboratories and research settings.

The increasing adoption of real-time PCR (qPCR) and next-generation sequencing (NGS) has further improved diagnostic precision. Molecular tests provide rapid results, reducing the need for repeated testing and enabling timely treatment decisions. Moreover, these technologies allow for antibiotic resistance detection, helping guide effective treatment strategies. Governments and healthcare organizations are promoting advanced diagnostic techniques to improve gastric disease management, driving demand. As automation in diagnostics and point-of-care molecular tests continue to advance, molecular diagnostics remains the leading technology in this market.

Non-invasive Helicobacter Pylori Testing Market- Geographical Insights

The Asia-Pacific non-invasive H. pylori testing market is expanding due to the high prevalence of H. pylori infections and increasing awareness of gastrointestinal diseases. Countries like China, India, and Japan have a significant burden of H. pylori-related conditions, driving the demand for early and accurate diagnostics. The adoption of urea breath tests (UBT) and stool antigen tests (SAT) is rising due to their reliability and non-invasive nature. Government initiatives promoting gastric cancer screening programs further support market growth. The expanding healthcare infrastructure, rising disposable income, and growing medical tourism in the region enhance accessibility to advanced diagnostics. Additionally, the increasing availability of home-based testing kits through e-commerce platforms is fueling market penetration. Technological advancements and regulatory approvals for innovative diagnostic solutions continue to shape the market landscape.

The non-invasive H. pylori testing market in China is witnessing strong growth due to the high prevalence of H. pylori infections, affecting nearly 50% of the population. The increasing awareness about gastric diseases, ulcers, and gastric cancer risks is driving the demand for early and non-invasive diagnostic methods. The Chinese government has been promoting gastric cancer screening programs, further accelerating market expansion.

Urea breath tests (UBT) are the most widely used method in China due to their high accuracy and convenience. The adoption of stool antigen tests (SAT) is also growing, particularly in hospitals and diagnostic laboratories. Meanwhile, the availability of home-based H. pylori testing kits is increasing, driven by the rise of e-commerce platforms and telemedicine services. Consumers prefer at-home diagnostics due to convenience, affordability, and reduced hospital visits.

Non-invasive Helicobacter Pylori Testing Market- Competitive Landscape:

The non-invasive H. pylori testing market is highly competitive, with companies focusing on technological advancements, product innovation, and strategic collaborations to expand their market share. Leading players such as Thermo Fisher Scientific, Abbott, and DiaSorin dominate with molecular diagnostics, immunoassay-based kits, and urea breath tests. Increasing R&D investments are enhancing test accuracy, while automation in diagnostic labs is improving efficiency.

The rise of home-based testing kits and digital healthcare solutions is further intensifying competition. Companies are also expanding their global distribution networks, especially in emerging markets. Regulatory approvals and government-backed screening programs continue to influence market dynamics.

Recent Developments:

In July 2023, Meridian Bioscience secured FDA clearance for its latest H. pylori diagnostic test, Premier HpSA Flex, marking a significant advancement in non-invasive testing. This development strengthened the company's position in the non-invasive H. pylori testing market and enhanced its diagnostic offerings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific Inc.
  • DiaSorin S.p.A.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • QuidelOrtho Corporation
  • Meridian Bioscience, Inc.
  • Coris BioConcept
  • Sekisui Diagnostics
  • Alfa Scientific Designs, Inc.
  • Halyard Health, Inc.
  • Kibion AB
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
  • CerTest Biotec S.L.
  • BIOHIT HealthCare Ltd.
  • Medline Industries, LP
  • Cardinal Health, Inc.
  • Luminex Corporation

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Urea Breath Test (UBT)
  • Stool Antigen Test (SAT)
  • Blood Antibody Test

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Immunoassay-Based Testing
  • Chromatographic Techniques

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY DISTRIBUTION- CHANNEL MARKET ANALYSIS, 2019 - 2032

  • Machine Translation Integration
  • Hospital-Based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care Settings

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Non-invasive Helicobacter Pylori Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Non-invasive Helicobacter Pylori Testing Market Snippet by Test Type
    • 2.1.2. Non-invasive Helicobacter Pylori Testing Market Snippet by Technology
    • 2.1.3. Non-invasive Helicobacter Pylori Testing Market Snippet by Distribution Channel
    • 2.1.4. Non-invasive Helicobacter Pylori Testing Market Snippet by End-user
    • 2.1.5. Non-invasive Helicobacter Pylori Testing Market Snippet by Country
    • 2.1.6. Non-invasive Helicobacter Pylori Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Non-invasive Helicobacter Pylori Testing Key Market Trends

  • 3.1. Non-invasive Helicobacter Pylori Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Non-invasive Helicobacter Pylori Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Non-invasive Helicobacter Pylori Testing Market Opportunities
  • 3.4. Non-invasive Helicobacter Pylori Testing Market Future Trends

4. Non-invasive Helicobacter Pylori Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Non-invasive Helicobacter Pylori Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Non-invasive Helicobacter Pylori Testing Market Landscape

  • 6.1. Non-invasive Helicobacter Pylori Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Non-invasive Helicobacter Pylori Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Urea Breath Test (UBT)
    • 7.1.3. Stool Antigen Test (SAT)
    • 7.1.4. Blood Antibody Test

8. Non-invasive Helicobacter Pylori Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Molecular Diagnostics
    • 8.1.3. Immunoassay-Based Testing
    • 8.1.4. Chromatographic Techniques

9. Non-invasive Helicobacter Pylori Testing Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
    • 9.1.2. Machine Translation Integration
    • 9.1.3. Hospital-Based Pharmacies
    • 9.1.4. Retail Pharmacies
    • 9.1.5. Online Pharmacies

10. Non-invasive Helicobacter Pylori Testing Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 10.1.2. Hospitals & Clinics
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Home Care Settings

11. Non-invasive Helicobacter Pylori Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. The U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Non-invasive Helicobacter Pylori Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific Inc.
    • 12.2.2. DiaSorin S.p.A.
    • 12.2.3. Abbott Laboratories
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. QuidelOrtho Corporation
    • 12.2.6. Meridian Bioscience, Inc.
    • 12.2.7. Coris BioConcept
    • 12.2.8. Sekisui Diagnostics
    • 12.2.9. Alfa Scientific Designs, Inc.
    • 12.2.10. Halyard Health, Inc.
    • 12.2.11. Kibion AB
    • 12.2.12. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
    • 12.2.13. CerTest Biotec S.L.
    • 12.2.14. BIOHIT HealthCare Ltd.
    • 12.2.15. Medline Industries, LP
    • 12.2.16. Cardinal Health, Inc.
    • 12.2.17. Luminex Corporation

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제